{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:06:17Z","timestamp":1792785977081,"version":"4.5.0"},"reference-count":18,"publisher":"Oxford University Press (OUP)","issue":"9","funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"name":"United States Government"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,21]]},"abstract":"<jats:title>Vignette<\/jats:title>\n                  <jats:p>A 65-yr-old White woman with obesity class II, hypertension, hyperlipidemia, obstructive sleep apnea, osteoarthritis, and pre-diabetes was started on s.c. semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1 RA), for weight loss. Her DXA BMD, 3\u00a0mo prior to the initiation of semaglutide, showed osteopenia. She did not have personal or family history of fractures. She had gone into menopause at the age of 52 with no other risk factors for osteoporosis. She maintains an adequate intake of calcium and cholecalciferol, and she is active but does not exercise regularly. After 1\u00a0yr on semaglutide, she lost ~15% of her weight with improvement of blood pressure, lipid profile, and sleeping pattern. She reports 2 recent falls. The initial recommendation was to repeat DXA in 2-3\u00a0yr. However, recent evidence suggests that in elderly patients experiencing ~9% weight loss with semaglutide, monitoring bone remodeling markers and BMD after 1\u00a0yr of treatment is justified. Counseling on adequate protein intake and strengthening exercise to preserve muscle mass should also be provided.<\/jats:p>","DOI":"10.1093\/jbmr\/zjag069","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T11:41:20Z","timestamp":1776339680000},"page":"940-944","source":"Crossref","is-referenced-by-count":2,"title":["Complex clinical encounter series: glucagon-like peptide-1 receptor agonists-induced weight loss: are we paying attention to bone health?"],"prefix":"10.1093","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5704-6072","authenticated-orcid":false,"given":"Elena","family":"Ambrogini","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine and Department of Orthopedics, University of Arkansas for Medical Sciences, Central Arkansas Veterans Healthcare System , Little Rock, AR, 72205 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"issue":"8","key":"2026082903271148000_ref1","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41573-025-01183-8","article-title":"GLP-1-based therapies for diabetes, obesity and beyond","volume":"24","author":"Drucker","year":"2025","journal-title":"Nat Rev Drug Discov"},{"issue":"10","key":"2026082903271148000_ref2","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1093\/jbmr\/zjaf091","article-title":"Body mass index and subsequent fracture risk: a meta-analysis to update FRAX(R)","volume":"40","author":"Harvey","year":"2025","journal-title":"J Bone Miner Res"},{"issue":"20","key":"2026082903271148000_ref3","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1056\/NEJMoa1616338","article-title":"Aerobic or resistance exercise, or both, in dieting obese older adults","volume":"376","author":"Villareal","year":"2017","journal-title":"N Engl J Med"},{"issue":"10","key":"2026082903271148000_ref4","doi-asserted-by":"publisher","first-page":"e1913733","DOI":"10.1001\/jamanetworkopen.2019.13733","article-title":"Effect of weight loss via severe vs moderate energy restriction on lean mass and body composition among postmenopausal women with obesity: the TEMPO diet randomized clinical trial","volume":"2","author":"Seimon","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"11","key":"2026082903271148000_ref5","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1002\/jbmr.3214","article-title":"The effect of intentional weight loss on fracture risk in persons with diabetes: results from the look AHEAD randomized clinical trial","volume":"32","author":"Johnson","year":"2017","journal-title":"J Bone Miner Res"},{"issue":"5","key":"2026082903271148000_ref6","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.jshs.2021.05.001","article-title":"Exercise attenuates bone mineral density loss during diet-induced weight loss in adults with overweight and obesity: a systematic review and meta-analysis","volume":"10","author":"Mesinovic","year":"2021","journal-title":"J Sport Health Sci"},{"issue":"6","key":"2026082903271148000_ref7","doi-asserted-by":"publisher","first-page":"e2516772","DOI":"10.1001\/jamanetworkopen.2025.16772","article-title":"Weighted vest use or resistance exercise to offset weight loss-associated bone loss in older adults: a randomized clinical trial","volume":"8","author":"Beavers","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"Suppl 1","key":"2026082903271148000_ref8","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/oby.24229","article-title":"The impact of lifestyle-based weight loss in older adults with obesity on muscle and bone health: a balancing act","volume":"33 Suppl 1","author":"Cortes","year":"2025","journal-title":"Obesity (Silver Spring)"},{"issue":"9","key":"2026082903271148000_ref9","doi-asserted-by":"publisher","first-page":"4674","DOI":"10.1111\/dom.16541","article-title":"The effects of anti-obesity medications on bone metabolism: a critical appraisal","volume":"27","author":"Anastasilakis","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"2026082903271148000_ref10","doi-asserted-by":"publisher","first-page":"102624","DOI":"10.1016\/j.eclinm.2024.102624","article-title":"Once-weekly semaglutide versus placebo in adults with increased fracture risk: a randomised, double-blinded, two-centre, phase 2 trial","volume":"72","author":"Hansen","year":"2024","journal-title":"eClinical Medicine."},{"key":"2026082903271148000_ref11","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgag052","article-title":"Skeletal effect of semaglutide and tirzepatide in patients with increased risk of fractures","author":"Liu","year":"2026","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026082903271148000_ref12","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/s41591-026-04204-0","article-title":"Bimagrumab plus semaglutide alone or in combination for the treatment of obesity: a randomized phase 2 trial","volume":"32","author":"Heymsfield","year":"2026","journal-title":"Nat Med"},{"issue":"11","key":"2026082903271148000_ref13","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1007\/s00198-025-07664-1","article-title":"Effects of glucagon-like peptide-1 receptor agonists on bone health in people living with obesity","volume":"36","author":"Karam","year":"2025","journal-title":"Osteoporos Int"},{"issue":"3","key":"2026082903271148000_ref14","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1002\/oby.24222","article-title":"Safety profile of semaglutide versus placebo in the SELECT study: a randomized controlled trial","volume":"33","author":"Kushner","year":"2025","journal-title":"Obesity (Silver Spring)"},{"key":"2026082903271148000_ref15","doi-asserted-by":"publisher","first-page":"112995","DOI":"10.1016\/j.diabres.2025.112995","article-title":"Association of tirzepatide use with risk of osteoporosis compared with other GLP-1 receptor agonists: a retrospective cohort study using the TriNetX database","volume":"230","author":"Hsu","year":"2025","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"2026082903271148000_ref16","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/oby.24172","article-title":"GLP1Ra-based therapies and DXA-acquired musculoskeletal health outcomes: a focused meta-analysis of placebo-controlled trials","volume":"33","author":"Beavers","year":"2025","journal-title":"Obesity (Silver Spring)"},{"issue":"8","key":"2026082903271148000_ref17","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1002\/oby.24336","article-title":"Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society","volume":"33","author":"Mozaffarian","year":"2025","journal-title":"Obesity (Silver Spring)"},{"key":"2026082903271148000_ref18","doi-asserted-by":"publisher","DOI":"10.1111\/bph.70355","article-title":"Glucagon-like peptide-1 receptor agonists and muscle strength changes in older adults: risks beyond muscle mass reductions","author":"Prokopidis","year":"2026","journal-title":"Br J Pharmacol"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jbmr\/advance-article-pdf\/doi\/10.1093\/jbmr\/zjag069\/68090635\/zjag069.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/41\/9\/940\/68090635\/zjag069.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/41\/9\/940\/68090635\/zjag069.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T07:27:21Z","timestamp":1787988441000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/41\/9\/940\/8655122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":18,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,4,16]]},"published-print":{"date-parts":[[2026,8,21]]}},"URL":"https:\/\/doi.org\/10.1093\/jbmr\/zjag069","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,4,16]]}}}